What's breaking now, across thousands of outlets.
The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
(MedPage Today) -- A single-use bioengineered liver paired with an extracorporeal blood circuit that replicates key functions of a human liver was shown to be safe among patients with syndromes of…
(MedPage Today) -- Testosterone use among females has risen since 2016 and is frequently prescribed without a documented diagnosis of hypoactive sexual desire disorder, the sole evidence-based…
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity…
Rumors and speculation have swirled all year about the fate of HHS Secretary Robert F. Kennedy Jr., the political face of the Make America Healthy Again movement.
Congressional Democrats are demanding pharmaceutical companies immediately disclose the un-redacted details of their “most favored nation” agreements with the Trump administration, according to a…
The prospective, multicenter, randomized phase 2 ZZ-FIRST clinical trial, led by the Vall d'Hebron Institute of Oncology's (VHIO) Prostate Cancer Group, evaluated the androgen receptor pathway…
